BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23270334)

  • 1. Correlation of the presence and extent of loss of heterozygosity mutations with histological classifications of Barrett's esophagus.
    Ellsworth E; Jackson SA; Thakkar SJ; Smith DM; Finkelstein S
    BMC Gastroenterol; 2012 Dec; 12():181. PubMed ID: 23270334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of mutational load in biopsy tissue provides additional information about genomic instability to histological classifications of Barrett's esophagus.
    Khara HS; Jackson SA; Nair S; Deftereos G; Patel S; Silverman JF; Ellsworth E; Sumner C; Corcoran B; Smith DM; Finkelstein S; Gross SA
    J Gastrointest Cancer; 2014 Jun; 45(2):137-45. PubMed ID: 24402860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOH at the sites of the DCC, APC, and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus.
    Dolan K; Garde J; Walker SJ; Sutton R; Gosney J; Field JK
    Hum Pathol; 1999 Dec; 30(12):1508-14. PubMed ID: 10667431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.
    Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ
    J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus.
    Eluri S; Brugge WR; Daglilar ES; Jackson SA; Styn MA; Callenberg KM; Welch DC; Barr TM; Duits LC; Bergman JJ; Shaheen NJ
    Am J Gastroenterol; 2015 Jun; 110(6):828-34. PubMed ID: 26010308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies.
    Romagnoli S; Roncalli M; Graziani D; Cassani B; Roz E; Bonavina L; Peracchia A; Bosari S; Coggi G
    Lab Invest; 2001 Feb; 81(2):241-7. PubMed ID: 11232646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus.
    Dolan K; Morris AI; Gosney JR; Field JK; Sutton R
    J Gastroenterol Hepatol; 2003 Jun; 18(6):683-9. PubMed ID: 12753151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus.
    Raja S; Finkelstein SD; Baksh FK; Gooding WE; Swalsky PA; Godfrey TE; Buenaventura PO; Luketich JD
    Ann Thorac Surg; 2001 Oct; 72(4):1130-5. PubMed ID: 11603424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma.
    Suspiro A; Pereira AD; Afonso A; Albuquerque C; Chaves P; Soares J; Leitão CN
    Am J Gastroenterol; 2003 Apr; 98(4):728-34. PubMed ID: 12738448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma.
    González MV; Artímez ML; Rodrigo L; López-Larrea C; Menéndez MJ; Alvarez V; Pérez R; Fresno MF; Pérez MJ; Sampedro A; Coto E
    J Clin Pathol; 1997 Mar; 50(3):212-7. PubMed ID: 9155671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.
    Rudolph RE; Vaughan TL; Kristal AR; Blount PL; Levine DS; Galipeau PC; Prevo LJ; Sanchez CA; Rabinovitch PS; Reid BJ
    J Natl Cancer Inst; 2003 May; 95(10):750-7. PubMed ID: 12759393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.
    Hage M; Siersema PD; Vissers KJ; Dinjens WN; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    Int J Cancer; 2006 Jan; 118(1):155-60. PubMed ID: 16032707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.
    Ramel S; Reid BJ; Sanchez CA; Blount PL; Levine DS; Neshat K; Haggitt RC; Dean PJ; Thor K; Rabinovitch PS
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1220-8. PubMed ID: 1551529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
    Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
    Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
    Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
    Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal chromosome 17q loss in Barrett's esophageal and gastric cardia adenocarcinomas: implications for tumorigenesis.
    Petty EM; Kalikin LM; Orringer MB; Beer DG
    Mol Carcinog; 1998 Aug; 22(4):222-8. PubMed ID: 9726814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE
    Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.